|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘 | Becker MA Schumacher HR Wortmann RL | 2005 | NEnglJMed2005，353，23： | 1 |
| 2 | Kinetics of the disproportionation of SnO显示文摘 | Porsch F Wortmann G | 2005 | Solid State Ionics2005，176，： | 1 |
| 3 | Dermatomyositis显示文摘 | Callen JP Wortmann RL | 2006 | Clin Dermatol2006，24，5： | 1 |
| 4 | Gout and hyperuricemia显示文摘 | Wortmann RL | 2002 | Curr Opin Rheumatol2002，14，3： | 1 |
| 5 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout 显示文摘 | Becker MA Schumacher HR Wortmann RL | 2005 | New En J Med2005，353，： | 1 |
| 6 | Annual soil improving legumes: Agronomic effectiveness, nutrient uptake, nitrogen fixation and water use 显示文摘 | Wortmann C S Mclntyre B D Kaizzi C K | 2000 | Field crop res2000，68，1： | 1 |
| 7 | Gout and hyperuricemia显示文摘 | Wortmann RL | 2002 | Cur Opin Rheumatol2002，14，： | 1 |
| 8 | Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout :A 28 - week, phase Ⅲ, ran- domized, double - blind, parallel - group trial 显示文摘 | Schumacher JRHR Becker MA Wortmann RL | 2008 | Arthritis Care Res2008，59，： | 1 |
| 9 | Febuxostat,a novel nonpurine selective inhibitor of xanthine oxidase:a twenty-eight-day,multicenter,phase Ⅱ,randomized,double-blind,placebo-controlled,dose-response clinical trial examining safety and efficacy in patients with gout显示文摘 | Becker M A Schumacher H R Jr Wortmann R L | | 0，，03： | 1 |
| 10 | Generic bill-of-material: A new product model 显示文摘 | Hegge H M H Wortmann J C | 1991 | International Journal of Production Economics1991，23，13： | 1 |
| 11 | Gout therapeutics: new drugs for an old disease 显示文摘 | Burns C M Wortmann R L | 2011 | Lancet2011，377，9760： | 1 |
| 12 | Dementia: a global health priority--highlights from an ADI and World Health Organization report显示文摘 | Wortmann M | 2012 | Alzhei- mer'' s Res Ther2012，4，5： | 1 |
| 13 | Genetic bill-of-material:a new product model显示文摘 | Hegge H M H Wortmann J C | 1991 | International Journal of Production Economics1991，23，： | 1 |
| 14 | Differentiating idiopathic inflammatory myopathies from metabolic myopathies显示文摘 | Wortmann RL DiMauro S | 2002 | Rherm Dis Clin N Am2002，28，： | 1 |
| 15 | Hepatie iron quantification by atomic absorption speetrophotometry: Full validation of an analytical method using a fast sample preparation 显示文摘 | Wortmann A C Froehlich P E Pinto R B | 2007 | Spectroscopy2007，21，3： | 1 |
| 16 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘 | Becker M A Schumacher H R Jr Wortmann R L | | 0，，23： | 1 |
| 17 | Generic Bill-of-material: A New Product Model显示文摘 | Wortmann J C | 1991 | International Journal of Production Economics1991，23，： | 1 |
| 18 | Fluorescent H-Aggregates of Merocyanine Dyes 显示文摘 | Ulrich Rosch Sheng Yao Rudiger Wortmann | 2006 | Angew Chem Int Ed2006，45，42： | 1 |
| 19 | New developme-ntts in generative BOM-processing systems显示文摘 | Veen E A VAN Wortmann J C | 1992 | Product Planning & Control1992，3，3： | 1 |
| 20 | GLP- 1 - analogues resistant to degredation by dipeptidyl - peptidase Ⅳ in vitro 显示文摘 | Gallwitz B Ropeter T Morys - Wortmann | 2000 | Regul Pept2000，86，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员